It disclosed that the dangerous paediatric cough syrups were being circulated in Gambia.
In a public health advisory issued by NAFDAC on Sunday, it stated it never registered the medicines, therefore it should not be in circulation in the country.
The advisory added: “We are notifying healthcare providers and the public of the death of 66 children in Gambia following the use of four substandard cough syrups as reported by WHO in September 2022.
“The four products are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup.”
